Author

M. Salvatore

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Approach:experimental assay· 3 Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2

Frequent Co-Authors

E. Ghedin· 2 shared A. Beaulieu· 1 shared A. Beheshti· 1 shared A. C. Borczuk· 1 shared A. Corvelo· 1 shared A. Craney· 1 shared A. Garcia-Sastre· 1 shared A. Geber· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Ghedin

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Interferon epsilon restricts Zika virus infection in the female reproductive tract

C. Xu, A. Wang, L. Ebraham, L. Sullivan, C. Tasker, V. Pizutelli, J. Couret, C. Hernandez, P. Q. Deb, L. Fritzky, S. Subbian, N. Gao, Y. Lo, M. Salvatore, A. Rivera, , T. L. Chang

This study shows that IFNε protects against vaginal ZIKV infection in mice by maintaining epithelial integrity and is effective even without IFNAR1 signaling.

PNAS Nexus · Oct 25, 2023Peer-reviewedImmunology

Reduced inflammatory response and promoted multiciliated cell differentiation in mice protected by defective interfering influenza virus

C. Wang, R. Honce, M. Salvatore, J. Yang, N. M. Twells, L. K. Mahal, S. Schultz-Cherry, E. Ghedin

This study shows that defective interfering influenza virus protects mice from viral infection by reducing inflammation and promoting multiciliated cell differentiation, independent of type I and III IFN signaling.

bioRxiv · Jan 25, 2022 · PreprintMicrobiology

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.

R. Rathnasinghe, M. Salvatore, H. Zheng, S. Jangra, T. Kehrer, I. Mena, M. Schotsaert, T. Muster, P. Palese, A. Garcia-Sastre

This study shows that a live attenuated influenza virus vaccine lacking NS1 provides broad protection against respiratory viruses including SARS-CoV-2 by inducing both innate and adaptive immune responses.

bioRxiv · Apr 28, 2021Microbiology

Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps

J. Park, J. Foox, T. Hether, D. Danko, S. Warren, Y. Kim, J. Reeves, D. J. Butler, C. Mozsary, J. Rosiene, A. Shaiber, E. Afshinnekoo, M. MacKay, Y. Bram, V. Chandar, , Schwar

This study identifies systemic tissue and cellular disruption from SARS-CoV-2 infection using autopsy and spatial omics data, showing tissue-specific damage and transcriptional changes.

bioRxiv · Mar 8, 2021 · PreprintMicrobiology

Microbial composition of the human nasopharynx varies according to influenza virus type and vaccination status.

T. Ding, T. Song, B. Zhou, A. Geber, Y. Ma, L. Zhang, M. Volk, S. N. Kapadia, S. G. Jenkins, M. Salvatore, E. Ghedin

The paper examines how influenza virus type and vaccination status influence nasopharyngeal microbiota composition in infected individuals and healthy controls.

bioRxiv · May 24, 2019Microbiology